Drugs / PvDBPII
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04201431 | Jan 2020 → Jul 2022 | Plasmodium vivax malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PvDBPII | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04201431 ↗ |
| Modality | Protein / enzyme biologic | “a protein/adjuvant formulation (PvDBPII/Matrix-M™)” PMID 35664997 ↗ May 2022 |